Chronic hepatitis B virus (HBV) is a long-term disease that requires monitoring to determine when to start therapy, evaluate ongoing disease activity, and assess on-treatment disease suppression. Drs. Paul Kwo and Mindie Nguyen discuss guideline approaches to starting and monitoring HBV treatment, how to mitigate complications, and barriers and disparities in HBV care and potential solutions for clinicians to provide optimal care for their patients.

Visit https://suitehome.atpointofcare.com/library/2663.03/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

For patients with chronic hepatitis B virus (HBV), many new therapies are in development with the objective of providing improved functional cure rates. We are also learning that combining therapies with different mechanisms of action may provide functional cure benefits that exceed those seen with monotherapy. Drs. Paul Kwo and Mindie Nguyen discuss new treatments in development for the treatment of chronic hepatitis B and the ongoing pivotal trials for these new therapies.

Visit https://suitehome.atpointofcare.com/library/2663.02/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Hepatitis B presents a huge health burden, affecting an estimated 2 million people in the US alone. In this episode, Dr. Paul Kwo and Dr. Mindie Nguyen discuss the disease burden, guideline-directed best practices for the screening, evaluation, and management of the disease, and therapy targets and functional cure.

Visit https://suitehome.atpointofcare.com/library/2663.01/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index.

Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index.

Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.